19 Years On And DDL Continues To Showcase The Best In Respiratory Drug Delivery

Main Category: Medical Devices / Diagnostics
Also Included In: Respiratory / Asthma;  Conferences
Article Date: 06 Nov 2008 - 1:00 PDT

email to a friend   printer friendly   view / write opinions   rate article

Bringing together the world's leading authorities in repiratory drug delivery, the organisers of the nineteenth Drug Delivery to the Lungs (DDL) conference are pleased to announce that this years' event will run from the 10th - 12th December at the Edinburgh International Conference Centre.

This year, the conference will span three days in a new format and remains the premiere European event for leaders in respiratory drug delivery to meet, present and discuss the latest technological advances in the treatment of respiratory diseases such as asthma, COPD (Chronic Obstructive Pulmonary Disease) and Cystic Fibrosis as well as in the field of systemic drug delivery via the respiratory tract.

Themed lecture session topics for this years' conference include:

- Novel therapies, formulations and animal models for respiratory disease
- The evolution of the interface between universities and industry: How academia contributes to the development of inhaled products
- Materials Science and Nanotechnology: Why polymer and particle properties matter so much - Quality by Design: Broadening the application and sharing the learnings

This year the conference will be supported by premier sponsors Pfizer, Novartis, 3M Drug Delivery Systems, Catalent Pharma Solutions and Bespak. As with previous years, the expected 400 plus delegates will have the opportunity to view leading edge technology poster presentations and review the latest technologies and services from over 30 exhibiting organisations.

Dr. Sandy Munro, Chairman of the DDL Committee commented: "The DDL conference continues to go from strength to strength. Attendance grows year on year and the scale and the eminence of the sponsors, exhibitors and delegates involved is a real testament to the quality of the programme, the excellent venue and value of the event to the inhaled product development community.

He continued, "Once again we predict another excellent conference programme, with topical lecture sessions hosted by, and featuring some of the industry's most eminent contributors."

A comprehensive lecture and speaker list will be confirmed and published online by the end of September. Delegate spaces are still available at a cost of £350 for a standard three day delegate rate, £200 for a three day Academic rate and £100 for a three day student rate. To book a delegate space please email admin@aerosol-soc.org.uk or telephone +44 (0) 1275 849019.

About DDL

Since 1986, The Aerosol Society has held an annual conference providing specialists in different fields of aerosol drug delivery to meet, present and then discuss and debate their work. Conference proceedings, in the form of bound extended abstracts, are then published and used as an invaluable reference tool for the Society's members. For more information please visit http://www.ddl-conference.org.uk

About The Aerosol Society

Formed in 1986 to provide a national forum whereby various groups involved in different aspects of aerosol research could interact and co-ordinate their efforts. The Society aims to promote all scientific branches of aerosol research, to promote the spread of information, to make available a pool of expert knowledge, to encourage international co-operation, assist in training, and to encourage investment in aerosol research. For more information please visit http://www.aerosol-soc.org.uk

The Aerosol Society